Q-Line Biotech Limited (NSE:QLINE)
India · Delayed Price · Currency is INR 699.55
+16.30 (2.39%)
At close: Sep 23, 2026
Q-Line Biotech Revenue
In the fiscal year ending March 31, 2026, Q-Line Biotech had annual revenue of 3.47B INR with 10.73% growth. Q-Line Biotech had revenue of 1.15B in the quarter ending March 31, 2026.
Revenue
3.47B
Revenue Growth
+10.73%
P/S Ratio
4.70
Revenue / Employee
11.10M
Employees
313
Market Cap
16.32B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 3.47B | 336.59M | 10.73% |
| Mar 31, 2025 | 3.14B | 1.10B | 54.08% |
| Mar 31, 2024 | 2.04B | 209.10M | 11.44% |
| Mar 31, 2023 | 1.83B | -1.21B | -39.92% |
| Mar 31, 2022 | 3.04B | 1.33B | 77.46% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Meghmani Organics | 21.03B |
| Suryoday Small Finance Bank | 14.07B |
| Utssav CZ Gold Jewels | 11.55B |
| Rajputana Stainless | 10.82B |
| Go Fashion (India) | 8.38B |
| Servotech Renewable Power System | 7.51B |
| IKIO Technologies | 6.44B |
| Divine Power Energy | 6.26B |